|
Hirudoid forte and placebo were applied for 10 days. Analgetics and anti-inflammatory agents were not used. Assessment criteria were pain on pressure, oedema and erythema.
|
|
|
特强喜疗妥制剂和安慰剂分别应用了10天。未应用止痛剂和消炎药。评估标准为压痛、水肿和红斑。 |
|
Hirudoid gel was very well tolerated.
|
|
|
喜疗妥凝胶的耐受性非常良好。 |
|
Hirudoid/Hirudoid forte also promote the regeneration of connective tissue by activating the synthesis of mesenchymal cells and by normalizing the water-binding capacity of the intercellular substance.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏还能透过促进间叶细胞的合成以及恢复细胞间质保持水分的能力从而促进结缔组织的再生。 |
|
Hirudoid/Hirudoid forte have a cream and gel base, which promote diffusion and are extremely well tolerated.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏含有的乳膏和凝胶基质能促进药物的扩散吸收，并且具有非常良好的耐受性。 |
|
Hirudoid/Hirudoid forte have an excellent local and systemic tolerability, no influence on blood coagulation has been observed.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏具有极好的局部和系统耐受性，不影响机体血凝系统。 |
|
Hirudoid/Hirudoid forte have local antithrombotic effects due to their influence on coagulation and fibrinolysis.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏作用于机体血液凝固系统和纤维蛋白溶解系统而具有局部的抗血栓作用。 |
|
Hirudoid/Hirudoid forte inhibit enzymes that cause tissue degeneration.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏能抑制导致组织分解代谢的酶。 |
|
Hirudoid/Hirudoid forte normalize the viscosity, permeability and water-binding capacity of the ground substance of the connective tissue.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏使结缔组织基质的粘性、渗透性和保持水分的能力恢复正常。 |
|
Hirudoid/Hirudoid forte prevent the formation and enhance the dissolution of superficial thrombi and microthrombi.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏不但能预防浅表血栓和微血栓的形成而且能促进其分解。 |
|
Hirudoid/Hirudoid forte promote the absorption of oedema and haematoma.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏能促进水肿和血肿的吸收。 |
|
Hirudoid/Hirudoid forte reduce swelling and inflammation.
|
|
|
喜疗妥乳膏/特强喜疗妥乳膏具有消肿和抗炎作用。 |
